首页> 外文期刊>BMC Nephrology >Estimating the total prevalence and incidence of end-stage kidney disease among Aboriginal and non-Aboriginal populations in the Northern Territory of Australia, using multiple data sources
【24h】

Estimating the total prevalence and incidence of end-stage kidney disease among Aboriginal and non-Aboriginal populations in the Northern Territory of Australia, using multiple data sources

机译:使用多种数据来源估算澳大利亚北领地原住民和非原住民人群终末期肾脏疾病的总患病率和发病率

获取原文
获取外文期刊封面目录资料

摘要

Most estimates for End Stage Kidney Disease (ESKD) prevalence and incidence are based on renal replacement therapy (RRT) registers. However, not all people with ESKD will commence RRT and estimates based only on RRT registry data will underestimate the true burden of ESKD in the community. This study estimates the total number of Northern Territory (NT) residents with ESKD including: those receiving RRT, those diagnosed but not receiving RRT and an estimate of “undiagnosed” cases. Four data sources were used to identify NT residents with a diagnosis of ESKD: public hospital admissions, Australia and New Zealand Dialysis and Transplant Registry registrations, death registrations and, for the Aboriginal population only, electronic primary care records. Three data sources contained information recorded between 1 July 2008 and 31 December 2013, death registration data extended to 31 December 2014 to capture 2013 prevalent cases. A capture–recapture method was used to estimate both diagnosed and undiagnosed cases by making use of probability patterns of overlapping multiple data sources. In 2013, the estimated ESKD prevalence in the NT Aboriginal population was 11.01 (95% confidence interval (CI) 10.24–11.78) per 1000, and 0.90 (95% CI 0.76–1.05) per 1000 in the NT non-Aboriginal population. The age-adjusted rates were 17.97 (95% CI 17.82–18.11) and 1.07 (95% CI 1.05–1.09) per 1000 in the NT Aboriginal and non-Aboriginal populations respectively. The proportion of individuals receiving RRT was 71.4% of Aboriginal and 75.5% of non-Aboriginal prevalent ESKD cases. The age-adjusted ESKD incidence was also greater for the Aboriginal (5.26 (95% CI 4.44–6.08) per 1000 population) than non-Aboriginal population (0.36 (95% CI 0.25–0.47) per 1000). This study provides comprehensive estimates of the burden of ESKD including those cases that are not identified in relevant health data sources. The results are important for informing strategies to reduce the total burden of ESKD and to manage the potential unmet demand, particularly from comparatively young Aboriginal patients who may be suitable for RRT but do not currently access the services for social, geographic or cultural reasons.
机译:对终末期肾脏病(ESKD)患病率和发病率的大多数估计都是基于肾脏替代疗法(RRT)登记册。但是,并非所有患有ESKD的人都将开始RRT,仅基于RRT注册中心数据进行的估算将低估社区中ESKD的真正负担。这项研究估计了北领地ESKD居民的总数,其中包括:接受RRT的人,被诊断但未接受RRT的人以及“未诊断”病例的估计。使用四个数据源来识别诊断为ESKD的NT居民:公立医院住院,澳大利亚和新西兰透析和移植注册登记,死亡登记,以及仅针对原住民的电子初级保健记录。三个数据来源包含2008年7月1日至2013年12月31日期间记录的信息,死亡登记数据延长至2014年12月31日,以记录2013年流行病例。捕获-捕获方法通过利用重叠多个数据源的概率模式来估计已诊断和未诊断的病例。 2013年,北领地土著人口的ESKD患病率估计为每1000人中有11.01人(95%置信区间(CI)10.24-11.78),而北领地非土著人口中每1000人中有0.90人(95%CI 0.76–1.05)。 NT土著居民和非土著居民的年龄调整率分别为17.97(95%CI 17.82-18.11)和1.07(95%CI 1.05-1.09)。接受RRT治疗的个人比例为原住民的71.4%,非原发性ESKD的75.5%。土著居民的年龄调整后的ESKD发生率也较高(每千人5.26(95%CI 4.44–6.08),而非土著人口(每千人0.36(95%CI 0.25–0.47))。这项研究提供了对ESKD负担的综合估计,包括在相关健康数据源中未发现的那些病例。这些结果对于制定减少ESKD的总负担和管理潜在的未满足需求的策略非常重要,尤其是对于那些可能适合RRT但由于社会,地理或文化原因目前无法使用该服务的相对年轻的原住民患者而言。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号